---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-242806"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:53:09.289019+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ResMed Q1 FY2025 revenue $1.22B (+11% YoY); EPS $2.11; non-GAAP EPS $2.20; dividend $0.53

## Summary
- Revenue $1,224.5M, up 11% YoY (11% constant currency), driven by sleep device and mask demand.
- GAAP diluted EPS $2.11; non-GAAP diluted EPS $2.20, up 34% YoY; operating profit up 34%.
- Gross margin improved to 58.6% (non-GAAP 59.2%), up 420 bps YoY on manufacturing efficiencies.
- Operating cash flow $326M; paid $78M dividends and repurchased $50M shares.
- Board declared quarterly dividend of $0.53 per share, record date Nov 7, payable Dec 12.

## SEC filing metadata
- accession: 0001193125-24-242806
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/0001193125-24-242806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/d859390d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-242806
- JSON: https://secwatch.observer/filing/0001193125-24-242806.json
- Plain text: https://secwatch.observer/filing/0001193125-24-242806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.